0001209191-20-063098.txt : 20201211 0001209191-20-063098.hdr.sgml : 20201211 20201211204147 ACCESSION NUMBER: 0001209191-20-063098 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201209 FILED AS OF DATE: 20201211 DATE AS OF CHANGE: 20201211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: D'Onofrio Matthew J CENTRAL INDEX KEY: 0001578770 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36075 FILM NUMBER: 201384862 MAIL ADDRESS: STREET 1: C/O EVOKE PHARMA, INC. STREET 2: 505 LOMAS SANTA FE DRIVE CITY: SOLANA BEACH STATE: CA ZIP: 92075 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evoke Pharma Inc CENTRAL INDEX KEY: 0001403708 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208447886 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 STEVENS AVENUE STREET 2: SUITE 370 CITY: SOLANA BEACH STATE: CA ZIP: 92075 BUSINESS PHONE: 858-345-1494 MAIL ADDRESS: STREET 1: 420 STEVENS AVENUE STREET 2: SUITE 370 CITY: SOLANA BEACH STATE: CA ZIP: 92075 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-09 0 0001403708 Evoke Pharma Inc EVOK 0001578770 D'Onofrio Matthew J C/O EVOKE PHARMA, INC. 420 STEVENS AVENUE, SUITE 370 SOLANA BEACH CA 92075 0 1 0 0 Exec VP, Chief Bus. Officer Common Stock 2020-12-09 4 M 0 46000 0.40 A 329997 D Stock Option (Right to Buy) 0.40 2020-12-09 4 M 0 46000 0.00 D 2021-02-09 Common Stock 46000 0 D These options were scheduled to expire on February 9, 2021. These options were fully vested as of February 9, 2015. /s/ Matthew J. D'Onofrio 2020-12-11